DNABW (Ginkgo Bioworks Holdings) ROCE %: -28.88% (As of Mar. 2026)


DNABW Ginkgo Bioworks Holdings Inc DNABW
63 GF Score
Price $0.00
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings ROCE %?

Ginkgo Bioworks Holdings DNABW -18.18% 63 ROCE % is -28.88% as of Mar. 2026. GuruFocus rates DNABW with a GF Score™ of 63/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ginkgo Bioworks Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was -28.88%.

Ginkgo Bioworks Holdings  (OTCPK:DNABW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ginkgo Bioworks Holdings ROCE % Related Terms

Ginkgo Bioworks Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings ROCE % Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -144.65 -98.61 -46.17 -39.50 -27.34

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.00 -21.41 -31.98 -30.42 -28.88
DNABW
63GF Score
Ginkgo Bioworks Holdings Inc DNABW
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings ROCE % Calculation

Ginkgo Bioworks Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-313.6/( ( (1377.449 - 107.266) + (1119.696 - 95.97) )/ 2 )
=-313.6/( (1270.183+1023.726)/ 2 )
=-313.6/1146.9545
=-27.34 %

Ginkgo Bioworks Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-285.496/( ( (1119.696 - 95.97) + (1033.075 - 79.595) )/ 2 )
=-285.496/( ( 1023.726 + 953.48 )/ 2 )
=-285.496/988.603
=-28.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -28.88% mean?
Ginkgo Bioworks Holdings (DNABW) has a ROCE % of -28.88% as of Mar. 2026.
Is Ginkgo Bioworks Holdings' ROCE % too high?
Ginkgo Bioworks Holdings' current ROCE % is -28.88%. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' ROCE % compare to CADL and CABA?
Ginkgo Bioworks Holdings' ROCE % of -28.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Ginkgo Bioworks Holdings's current ROCE % is -28.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current ROCE % of -28.88%. The current ROCE % is -28.88%. Ginkgo Bioworks Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current ROCE % is -28.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
63GF Score

Get the complete analysis for DNABW

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price